Contract analysis

1. Introduction and Purpose of Letter This letter provides our quarterly status update for the second quarter of 2023 (Q2 2023) on the above-referenced matter. We are pleased to report significant progress on multiple fronts, and we believe Lumos Analytics Inc. ("Lumos" or the "Company") is in a strong litigation posture as we approach the second half of 2023. As you know, this matter involves claims for trade-secret

2. Summary of Prior Proceedings (Q1 2023) For ease of reference, we briefly summarize the key proceedings from the first quarter of 2023, which laid the foundation for the significant progress achieved this quarter. 2.1 Temporary Restraining Order On January 19, 2023—the same day the Verified Complaint was filed—we submitted an ex parte application for a Temporary Restraining Order ("TRO") on Lumos's behalf. The appl

1. LumosEdge Ensemble ML Model Architecture — The proprietary neural-network topology and hyperparameter configurations underlying the LumosEdge platform, which represent years of research and development and constitute the core intellectual property of Lumos's flagship product.

2. Proprietary Feature-Engineering Libraries — The Company's feature-engineering libraries containing 2,847 individual engineered features, developed through extensive iterative testing and refinement, and representing a critical competitive advantage in Lumos's predictive analytics capabilities.

3. DataStream ETL Pipeline Codebase and Data-Schema Definitions — The codebase and associated data-schema definitions for the DataStream Extract, Transform, Load ("ETL") pipeline, covering data ingestion from 43 alternative-data vendors, and reflecting years of vendor-specific integration work and proprietary data-normalization processes.

4. Curated Training Dataset — The curated training dataset of approximately 14.6 terabytes, compiled and refined over several years at substantial cost, representing a proprietary asset that would be extremely difficult and expensive for a competitor to replicate independently.

5. Confidential Product Roadmap Documents (2023–2025) — Confidential product roadmap documents for 2023 through 2025, including the unreleased LumosEdge 3.0 specifications (a 37-page document), which detail strategic product plans, feature development timelines, and market positioning strategies not yet disclosed to the public. The formal Preliminary Injunction Order was entered on February 17, 2023. As of the date o

3. Forensic Examination — Brindoval Digital Forensics LLC One of the most significant developments of Q2 2023 was the completion of the forensic imaging process and the issuance of the Preliminary Forensic Report, both of which substantially corroborate and strengthen Lumos's claims. We summarize the relevant developments below. 3.1 Appointment of Neutral Forensic Examiner On March 8, 2023, following discussions betw

4. Fact discovery — Depositions A central objective of Q2 2023 was the completion of depositions of the three individual Defendants. We are pleased to report that all three depositions have now been taken. The key highlights of each deposition are summarized below. 4.1 Deposition of Rajiv Anand (May 15, 2023) The deposition of Rajiv Anand was conducted on May 15, 2023, at the offices of Calderwood & Harkness LLP, 555

5. Additional discovery — Written discovery Status In addition to the deposition program described above, we have been pursuing written discovery to build a comprehensive evidentiary record. On March 20, 2023, we served Plaintiff's First Set of Requests for Production of Documents and Plaintiff's First Sets of Special Interrogatories to both Rajiv Anand and NovaSpark Technologies Inc. Responses to these discovery req

6. Protective Order The Stipulated Protective Order was entered by the Court on March 15, 2023. The Protective Order establishes two tiers of confidentiality designations: • "Confidential" — Materials designated as "Confidential" may be viewed by counsel, retained experts, and designated in-house personnel of the producing and receiving parties. • "Attorneys' Eyes Only" — Materials designated as "Attorneys' Eyes Only

7. Upcoming Milestones and Recommended Next Steps Looking ahead, we identify the following milestones and offer our recommendations for next steps. 7.1 Remaining discovery and Damages Analysis As fact discovery nears completion, the litigation will transition into the expert discovery phase. A central component of expert discovery will be damages quantification. Lumos's damages theory will need to address, among othe

8. Fees and Costs Update Calderwood & Harkness LLP's professional fees incurred through June 30, 2023 will be reflected in our forthcoming monthly invoice, which you should expect to receive in the ordinary course. The following team members are currently staffed on this matter: In addition to professional fees, the following third-party costs have been incurred to date in connection with this matter: • Brindoval Dig

9. Conclusion Overall, the matter is progressing favorably, and Lumos is in a strong litigation posture. The forensic evidence confirmed by the Brindoval Preliminary Forensic Report, the preliminary injunction that remains in full force and effect, and the admissions obtained through the depositions of all three individual Defendants collectively provide robust support for Lumos's claims. Defendants face significant